GPCR · ISSUER CIK 1888886
Structure Therapeutics Inc.
Between Aug 1, 2026 and Oct 29, 2026, 3 Structure Therapeutics Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Sep 22, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 202617:59 | Sep 18, 2026 | GPCR | CHIEF MEDICAL OFFICER | F · Tax10b5-1 | $11.67 | −10,626 | 270,252 | -4% | $124K | ||
| Sep 22, 202617:59 | Sep 21, 2026 | GPCR | CHIEF MEDICAL OFFICER | C · Convert10b5-1 | — | −12,024 | 258,228 | -4% | — | ||
| Sep 2, 202621:18 | Sep 1, 2026 | GPCR | CHIEF SCIENTIFIC OFFICER | M · Exercise10b5-1 | $0.34 | +17,817 | 246,777 | +8% | $6K | ||
| Sep 2, 202621:18 | Sep 1, 2026 | GPCR | CHIEF SCIENTIFIC OFFICER | C · Convert10b5-1 | — | −17,817 | 228,960 | -7% | — | ||
| Aug 19, 202620:23 | Aug 18, 2026 | GPCR | CHIEF SCIENTIFIC OFFICER | M · Exercise10b5-1 | $0.34 | +11,817 | 240,777 | +5% | $4K | ||
| Aug 19, 202620:23 | Aug 18, 2026 | GPCR | CHIEF SCIENTIFIC OFFICER | C · Convert10b5-1 | — | −11,817 | 228,960 | -5% | — | ||
| Aug 7, 202616:08 | Aug 6, 2026 | GPCR | Chief Commercial Officer | A · Grant | — | +140,766 | 140,766 | New | — | ||
| Aug 5, 202616:49 | Aug 4, 2026 | GPCR | CHIEF SCIENTIFIC OFFICER | M · Exercise10b5-1 | $0.34 | +11,817 | 240,777 | +5% | $4K | ||
| Aug 5, 202616:49 | Aug 4, 2026 | GPCR | CHIEF SCIENTIFIC OFFICER | C · Convert10b5-1 | — | −11,817 | 228,960 | -5% | — |